none title certification

MB Canno Biosciences Finance - revenue, profit

eye icon
More information

EBITDA margin (%)

unlock data icon

Register and

explore Okredo data
More information

EBIT margin (%)

unlock data icon

Register and

explore Okredo data
Financial report background

Financial statement report

Price: €9.90
Premium users: 1.00 credit
Indicator
Turnover (€)
Sales per employee (€)info
Profit before tax (€)
Net Profit (€)
Profit per employee (€)info
Total profitability (%)info
Net profitability (%)info
Equity (€)
Amounts Payable And Liabilities (€)
Non-current Assets (€)
CurrentAssets (€)
Working capital requirementinfo
Debt-to-equity ratioinfo
EBITDA margin (%)info
EBITDA (€)info
EBIT margin (%)info
EBIT (€)info
2022
2,335
-
90
90
-
91.09
3.85
2,975
0
0
2,975
2023
4,283
-
-1,385
-1,385
-
73.38
-32.34
3,318
200
0
3,518
2024
1,070
-
759
759
-
81.87
70.93
4,077
0
0
4,077
unlock data icon

Register and

explore Okredo data
2024
1,070
-
759
759
-
81.87
70.93
4,077
0
0
4,077
unlock data icon

Register and

explore Okredo data

2024

Turnover (€)

1,070 €Descended-75 % *

Sales per employee (€)

-

Profit before tax (€)

759 €Ascended155 % *

Net Profit (€)

759 €Ascended155 % *

Profit per employee (€)

-

Total profitability (%)

81.87 %Ascended11.57 % *

Net profitability (%)

70.93 %Ascended319.33 % *

Equity (€)

4,077 €Ascended23 % *

Amounts Payable And Liabilities (€)

0 €Descended-100 % *

Non-current Assets (€)

0 €Ascended- *

CurrentAssets (€)

4,077 €Ascended16 % *

*over the last year starting selected period